Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 11, 2011 - Issue 3
Submit an article Journal homepage
24
Views
0
CrossRef citations to date
0
Altmetric
Meeting Report

Pioneering the trail of cancer immunotherapy

Beatrix Kotlan Center of Surgical and Molecular Tumor Pathology, National Institute of Oncology, Budapest, 1122 Rath Gy Street 7–9, Hungary. [email protected]; Center of Surgical and Molecular Tumor Pathology, National Institute of Oncology, Budapest, 1122 Rath Gy Street 7–9, Hungary. [email protected]
&
James M Balwit Society for Immunotherapy of Cancer, 555 East Wells Street, Suite 1100, Milwaukee, WI 53202-3823, USA; Society for Immunotherapy of Cancer, 555 East Wells Street, Suite 1100, Milwaukee, WI 53202-3823, USA
Pages 351-354 | Published online: 10 Jan 2014

References

  • Butterfield LH, Disis ML, Fox BE et al. A systematic approach to biomarker discovery: preamble to ‘the iSBTC-FDA Taskforce on Immunotherapy Biomarkers’. J. Transl. Med.6, 81 (2008).
  • Butterfield LH, Disis ML, Khleif SN, Balwit JM, Marincola FM. Immuno-Oncology Biomarkers 2010 and beyond: perspectives from the iSBTc/SITC Biomarker Task Force. J. Transl. Med.8, 130 (2010).
  • Higano CS, Schellhammer PF, Small EJ et al. CD54 expression by APC – sipuleucel-T cellular immunotherapy – metastatic prostate cancer. Cancer115, 3670–3679 (2009).
  • Marincola FM, Wang EE. Immunologic Signatures of Rejection (1st Edition). Springer NY, USA, ISBN: 978-1-4419-7218-7 (2011).
  • Bedognetti D, Wang E, Sertoli MR, Marincola FM. Gene-expression profiling in vaccine therapy and immunotherapy for cancer. Expert Rev. Vaccines9(6), 555–565 (2010).
  • Balwit JM, Hwu P, Urba WJ, Marincola FM. The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program Transl. Med.9, 18 (2011).
  • Bauerle PA, Reinhardt C. Bispecific T-cell Engaged antibodies for cancer therapy. Cancer Res.69, 4941–4944 (2009).
  • Abstracts for the 25th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer. J. Immunotherapy33, 859–920 (2010).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.